Clinical diagnosis, monitoring and biomarkers in ILDs

M. Kreuter (Heidelberg, Germany)

Source: ERS Course 2016

Number: 1

Disease area: Interstitial lung diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Kreuter (Heidelberg, Germany). Clinical diagnosis, monitoring and biomarkers in ILDs. ERS Course 2016

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Evaluation of new biomarkers for laboratory diagnosis of tuberculosis Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools Year: 2018
Clinical diagnosis of COPD Source: Virtual Congress 2020 – Russian speaking programme 2020: Part II Year: 2020
Clinical aspects of ILDs Source: ERS Online Course 2019: Biopsy techniques and pathology of ILD Year: 2019
Predictive value of clinical diagnosis in sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 345s Year: 2001
Diagnostic work-up and treatment of patients with acute ILDs Source: International Congress 2018 – PG15 Challenging issues in acute interstitial lung diseases Year: 2018
Clinical approach to the diagnosis and assessment of AATD Source: Eur Respir Monogr 2019; 85: 64-77 Year: 2019
Diagnostic and prognostic value of advanced imaging modalities in patients with suspected cardiac sarcoidosis Source: International Congress 2016 – Sarcoidosis Year: 2016
Importance of admission biomarkers in prognostication of patients with SARS-Cov-2 Source: Virtual Congress 2021 – COVID-19 and acute respiratory failure Year: 2021
Diagnostic work-up in patients with acute ILDs Source: International Congress 2017 – PG11 Acute interstitial lung diseases (ILD) Year: 2017
Clinical pitfalls in diagnosing interstitial lung disease Source: International Congress 2014 – PG02 Current clinical problems in pulmonology Year: 2014
Clinical prognostic tools and their use in COPD. Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD Year: 2020
Prognostic validation of cryobiopsy for the diagnosis of interstitial lung diseases Source: International Congress 2019 – Transbronchial cryobiopsy and endobronchial ultrasound Year: 2019
Non-invasive inflammatory markers can predict diagnosis, severity and stability of paediatric asthma Source: Eur Respir J 2006; 28: Suppl. 50, 122s Year: 2006
Radiologic evaluation of ILDs Source: ERS Courses: Interstitial Lung Diseases Year: 2019
Radiologic evaluation of ILDs Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2018
Radiologic evaluation of ILDs Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2019
Radiologic evaluation of ILDs Source: ERS Course 2016 Year: 2016
Diagnosis and assessment of asthma Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=180 Year: 2003
Biomarkers for clinical management Source: International Congress 2017 – PG12 Life-threatening pulmonary infections Year: 2017